Related Experiment Videos
Summary
Rous sarcoma virus has a transcriptional activator that enhances gene expression. This activity originates from an alternate reading frame within the gag gene, impacting the LTR promoter region.
Area of Science:
- Molecular Biology
- Virology
- Gene Regulation
Background:
- Rous sarcoma virus (RSV) possesses regulatory elements influencing gene expression.
- Understanding viral transcriptional activators is crucial for deciphering viral pathogenesis and gene therapy applications.
Purpose of the Study:
- To identify and characterize a transcriptional activator expressed by Rous sarcoma virus.
- To map the genetic origin and determine the mechanism of action of this viral activator.
Main Methods:
- Transient gene expression assays in NIH 3T3 cells using LTR-promoted and rat preproinsulin II gene constructs.
- RNA splicing analysis to identify the specific mRNA transcript.
- Mapping the transcriptional activator to a specific region within the RSV gag gene.
Main Results:
- A transcriptional activator was identified, stimulating gene expression from the RSV LTR and other promoters.
- The activity was mapped to an alternate reading frame within the p19-p10 region of the gag gene.
- A novel mRNA transcript, differing by a 282-nucleotide splice, was identified, likely directing the translation of a 124-amino acid polypeptide.
Conclusions:
- RSV expresses a novel transcriptional activator encoded in an alternate reading frame of the gag gene.
- This activator modulates gene expression by targeting the RSV LTR promoter region.
- The findings provide new insights into the complex gene regulation strategies of retroviruses.